Staging of hepatocellular carcinoma

Area of Science:

• Hepatology
• Oncology
• Medical Imaging

Background:

• Hepatocellular carcinoma (HCC) prognosis depends on tumor stage and liver function, complicated by cirrhosis.
• Numerous staging systems exist, including European (BCLC, CLIP) and Asian (Okuda, JIS) models.

Purpose of the Study:

• To review and compare various Hepatocellular carcinoma staging systems.
• To guide the selection of an appropriate staging system, particularly within the Indian healthcare context.
• To detail methods for assessing extra-hepatic spread in Hepatocellular carcinoma.

Main Methods:

• Review of existing Hepatocellular carcinoma staging systems.
• Comparative analysis of European and Asian staging models.
• Description of diagnostic imaging techniques for extra-hepatic spread assessment (PET/CT, CT, bone scan).

Main Results:

• The Barcelona Clinic Liver Cancer (BCLC) staging system is highlighted as a preferred model.
• BCLC integrates tumor status, liver function (Child-Pugh), and patient's general health (ECOG, symptoms).
• Extra-hepatic spread commonly involves lymph nodes, lungs, and bones, detectable via PET/CT or CT/bone scan combinations.

Conclusions:

• The BCLC staging system offers a comprehensive approach to Hepatocellular carcinoma management.
• Appropriate staging is crucial for accurate prognosis and treatment planning in Hepatocellular carcinoma.
• Effective assessment of extra-hepatic spread is vital for treatment decisions in Hepatocellular carcinoma.